For: | Nakayama T, Hatachi G, Wen CY, Yoshizaki A, Yamazumi K, Niino D, Sekine I. Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors. World J Gastroenterol 2005; 11(7): 964-969 [PMID: 15742397 DOI: 10.3748/wjg.v11.i7.964] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i7/964.htm |
Number | Citing Articles |
1 |
Cristine Dieter, Natália Emerim Lemos, Nathalia Rodrigues de Faria Corrêa, Taís Silveira Assmann, Felipe Mateus Pellenz, Luís Henrique Canani, Letícia de Almeida Brondani, Andrea Carla Bauer, Daisy Crispim. Polymorphisms in TIE2 and ANGPT-1 genes are associated with protection against diabetic retinopathy in a Brazilian population. Archives of Endocrinology and Metabolism 2023; 67(5) doi: 10.20945/2359-3997000000624
|
2 |
Wenchao Zhou, Qunfeng Zhang, Junling Chen, Jinpeng Gan, Yukun Li, Juan Zou. Angiopoietin-4 expression and potential mechanisms in carcinogenesis: Current achievements and perspectives. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01449-2
|
3 |
Minna W.B. Olsen, Carsten D. Ley, Nanna Junker, Anker J. Hansen, Eva L. Lund, Paul E.G. Kristjansen. Angiopoietin-4 Inhibits Angiogenesis and Reduces Interstitial Fluid Pressure. Neoplasia 2006; 8(5): 364 doi: 10.1593/neo.06127
|
4 |
Michio Ozeki, Akifumi Nozawa, Norio Kawamoto, Akihiro Fujino, Satoshi Hirakawa, Toshiyuki Fukao. Potential biomarkers of kaposiform lymphangiomatosis. Pediatric Blood & Cancer 2019; 66(9) doi: 10.1002/pbc.27878
|
5 |
F. Bach, F.J. Uddin, D. Burke. Angiopoietins in malignancy. European Journal of Surgical Oncology (EJSO) 2007; 33(1): 7 doi: 10.1016/j.ejso.2006.07.015
|
6 |
Sebastian Niedźwiecki, Tomasz Stępień, Krzysztof Kopeć, Krzysztof Kuzdak, Jan Komorowski, Roman Krupiński, Henryk Stępień. Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers. Cytokine 2006; 36(5-6): 291 doi: 10.1016/j.cyto.2007.02.008
|
7 |
Paul-Eduard Neagoe, Alexandre Brkovic, Fadi Hajjar, Martin G. Sirois. Expression and release of angiopoietin-1 from human neutrophils: Intracellular mechanisms. Growth Factors 2009; 27(6): 335 doi: 10.3109/08977190903155043
|
8 |
ZHONG-LIN ZHANG, JI-FA ZHANG, YU-FENG YUAN, YUE-MING HE, QUAN-YAN LIU, XIAO-WEN MAO, YONG-BIAO AI, ZHI-SU LIU. Suppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody. Experimental and Therapeutic Medicine 2014; 7(3): 543 doi: 10.3892/etm.2014.1476
|
9 |
Roy S Herbst. Therapeutic options to target angiogenesis in human malignancies. Expert Opinion on Emerging Drugs 2006; 11(4): 635 doi: 10.1517/14728214.11.4.635
|
10 |
Masumi Ishibashi, Masafumi Toyoshima, Xuewei Zhang, Junko Hasegawa-Minato, Shogo Shigeta, Toshinori Usui, Christopher J. Kemp, Carla Grandori, Kazuyuki Kitatani, Nobuo Yaegashi. Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31069-2
|
11 |
Andrew Moss. The angiopoietin:Tie 2 interaction: A potential target for future therapies in human vascular disease. Cytokine & Growth Factor Reviews 2013; 24(6): 579 doi: 10.1016/j.cytogfr.2013.05.009
|
12 |
Hanako Kobayashi, Laura M. DeBusk, P. Charles Lin. Antiangiogenic Agents in Cancer Therapy. Cancer Drug Discovery and Development 2008; : 171 doi: 10.1007/978-1-59745-184-0_10
|
13 |
Abhinav Agarwal, Abhay Asthana, Umesh Gupta, Narendra K Jain. Tumour and dendrimers: a review on drug delivery aspects. Journal of Pharmacy and Pharmacology 2008; 60(6): 671 doi: 10.1211/jpp.60.6.0001
|
14 |
T. Makinde, D.K. Agrawal. Intra and extravascular transmembrane signalling of angiopoietin‐1‐Tie2 receptor in health and disease. Journal of Cellular and Molecular Medicine 2008; 12(3): 810 doi: 10.1111/j.1582-4934.2008.00254.x
|
15 |
Ewa Kopczynska, Maciej Dancewicz, Janusz Kowalewski, Roman Makarewicz, Hanna Kardymowicz, Agnieszka Kaczmarczyk, Tomasz Tyrakowski. Time-Dependent Changes of Plasma Concentrations of Angiopoietins, Vascular Endothelial Growth Factor, and Soluble Forms of Their Receptors in Nonsmall Cell Lung Cancer Patients Following Surgical Resection. ISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/638352
|
16 |
Jun Wang, Kai-Chun Wu, De-Xin Zhang, Dai-Ming Fan. Antisense angiopoietin-1 inhibits tumorigenesis and angiogenesis of gastric cancer. World Journal of Gastroenterology 2006; 12(15): 2450-2454 doi: 10.3748/wjg.v12.i15.2450
|
17 |
Ying-zhi ZHOU, Xue-qiang FANG, Hao LI, Yu-tao DIAO, Yan-fang YANG, De-li ZHAO, Kan WU, Hui-qing LI. Role of serum angiopoietin-2 level in screening for esophageal squamous cell cancer and its precursors. Chinese Medical Journal 2007; 120(14): 1216 doi: 10.1097/00029330-200707020-00002
|
18 |
Jennifer M Kirstein, Ann F. Chambers. Experimental and Clinical Metastasis. 2013; : 11 doi: 10.1007/978-1-4614-3685-0_2
|
19 |
Yu-Chen Cai, Hang Yang, Ke-Feng Wang, Tan-Huan Chen, Wen-Qi Jiang, Yan-Xia Shi. ANGPTL4 overexpression inhibits tumor cell adhesion and migration and predicts favorable prognosis of triple-negative breast cancer. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07343-w
|
20 |
Fang‐Tao Wang, Xin‐Ping Li, Mu‐Su Pan, Mohamed Hassan, Wei Sun, Yue‐Zu Fan. Identification of the prognostic value of elevated ANGPTL4 expression in gallbladder cancer‐associated fibroblasts. Cancer Medicine 2021; 10(17): 6035 doi: 10.1002/cam4.4150
|
21 |
Enni Chen, Jiajia Huang, Miao Chen, Jiawei Wu, Puyun Ouyang, Xiaonan Wang, Dingbo Shi, Zhiqiao Liu, Wancui Zhu, Haohui Sun, Shanshan Yang, Baoyu Zhang, Wuguo Deng, Huijuan Qiu, Fangyun Xie. FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-03986-y
|
22 |
Wenjing Xu, Wei Li, Yaqiang Li, Dayu Kuai, Wei Sun, Xian Liu, Baohong Xu. Genetic insights into blood protein correlations with colorectal cancer: a Mendelian randomization study. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01584-y
|
23 |
Jenn-Jhy Tseng, Min-Min Chou. Differential Expression of Growth-, Angiogenesis- and Invasion-Related Factors in The Development of Placenta Accreta. Taiwanese Journal of Obstetrics and Gynecology 2006; 45(2): 100 doi: 10.1016/S1028-4559(09)60205-9
|
24 |
Ren Chong Xi, Wang Shou Biao, Zhang Zhi Gang. Significant Elevation of Survivin and Livin Expression in Human Colorectal Cancer: Inverse Correlation between Expression and Overall Survival. Onkologie 2011; 34(8): 428 doi: 10.1159/000331132
|
25 |
Andrew Gaya, Vivien Tse. A preclinical and clinical review of aflibercept for the management of cancer. Cancer Treatment Reviews 2012; 38(5): 484 doi: 10.1016/j.ctrv.2011.12.008
|
26 |
Jenn J. Tseng, Shih L. Hsu, Esther Shih C. Ho, Yun T. Hsieh, Mei C. Wen, Min M. Chou. Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta. American Journal of Obstetrics and Gynecology 2006; 194(2): 564 doi: 10.1016/j.ajog.2005.07.012
|
27 |
Yan Wei, Panpan Yu, Zouyu Zhao, Chongfeng Sun, Qianyu Sun, Rui Bai, Weirui Gao, Ping Yang. Cervical cancer cell-derived Tie1 expression via PI3K/AKT signaling pathway promotes tumor progression. Experimental Cell Research 2024; 439(1): 114060 doi: 10.1016/j.yexcr.2024.114060
|
28 |
Sazan Rasul, Marie Helene Reiter, Aysegul Ilhan, Katharina Lampichler, Ludwig Wagner, Alexandra Kautzky-Willer. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study. Cardiovascular Diabetology 2011; 10(1) doi: 10.1186/1475-2840-10-55
|
29 |
S. K. NADAR, A. BLANN, D. G. BEEVERS, G. Y. H. LIP. Abnormal angiopoietins 1&2, angiopoietin receptor Tie‐2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub‐study of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT)]. Journal of Internal Medicine 2005; 258(4): 336 doi: 10.1111/j.1365-2796.2005.01550.x
|
30 |
H. M. C. Shantha Kumara, Michael J. Grieco, Xiaohong Yan, Matthew F. Kalady, Vincent DiMaggio, Donald G. Kim, Neil Hyman, Daniel L. Feingold, Richard L. Whelan. Minimally invasive colorectal resection for cancer is associated with a short-lived decrease in soluble Tie-2 receptor levels, which may transiently inhibit VEGF-mediated angiogenesis (via altered blood levels of free Ang-1 and Ang-2). Surgical Endoscopy 2010; 24(10): 2581 doi: 10.1007/s00464-010-1008-z
|
31 |
Clare T. Butler, Susan A. Kennedy, Amy Buckley, Ronan Doyle, Emer Conroy, William M. Gallagher, Jacintha O’Sullivan, Breandán N. Kennedy. 1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours. Oncotarget 2019; 10(38): 3725 doi: 10.18632/oncotarget.26966
|
32 |
Wen-chao Zhou, Qun-feng Zhang, Jun-ling Chen, Jin-peng Gan, Yu-kun Li, Juan Zou. RETRACTED ARTICLE: Angiopoietin4 (ANGPT4) expression and potential mechanisms in carcinogenesis: current achievements and perspectives. Clinical and Experimental Medicine 2023; 23(8): 4449 doi: 10.1007/s10238-023-01178-y
|